Second trimester two-step trisomy 18 screening using maternal serum markers

Prenatal Diagnosis

Volumn 22, Issue 7, 2002, Pages 605-608

  Muller, Françoise ^a   Sault, Corinne ^b   Lemay, Catherine ^c   Roussel Mizon, Nathalie ^c   Forestier, François ^d   Frendo, Jean Louis ^e  

^a HÔPITAL AMBROISE PARÉ   (France)

^b LMM Laboratoire Marcel Merieux   (France)

^c AMIENS UNIVERSITY HOSPITAL   (France)

^d Institut de Puericulture   (France)

^e INSERM   (France)

Author keywords

AFP; Biochemical screening; Free hCG; PAPP A; Prenatal screening; Trisomy 18

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A; BIOLOGICAL MARKER;

ADULT; AMNIOCENTESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; FEMALE; FETUS; HUMAN; PRIORITY JOURNAL; SCREENING TEST; SECOND TRIMESTER PREGNANCY; SERUM; TRISOMY 18; BLOOD; CHROMOSOME 18; GENETICS; LABORATORY DIAGNOSIS; MASS SCREENING; METHODOLOGY; PREGNANCY; PRENATAL DIAGNOSIS; TRISOMY;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOMES, HUMAN, PAIR 18; FALSE POSITIVE REACTIONS; FEMALE; HUMAN; MASS SCREENING; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY-ASSOCIATED ALPHA-PLASMA PROTEIN; PRENATAL DIAGNOSIS; TRISOMY; HUMANS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A;

EID: 0035990140     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.345     Document Type: Article

References (21)

1. Identification of second trimester fetuses with autosomal trisomy by use of a sonographic scoring index
2. Maternal serum screening for fetal trisomy 18: A comparison of fixed cut-off and patient-specific risk protocol
3. Maternal serum pregnancy-associated plasma protein A (PAPP-A) but not pregnancy-specific β1-glycoprotein (SP1) is a useful second-trimester marker for fetal trisomy 18
4. A role for maternal serum screening in detecting chromosomal abnormalities in fetuses with isolated choroid plexus cysts: A prospective multicentre study
5. Ultrasound findings and multiple marker screening in trisomy 18
6. Prenatal screening for trisomy 18 in the second trimester
7. Prenatal ultrasound findings in affected and unaffected pregnancies that are screen-positive for trisomy 18: The California experience
8. Detection of chromosomal abnormalities, an outcome of ultrasound screening. The Eurofetus Team
9. Choroid plexus cysts and trisomy 18: Risk modification based on maternal age and multiple-marker screening
10. Isolated choroid plexus cysts and trisomy 18: A review and meta-analyses
11. Maternal serum screening for trisomy 18: Assessing different statistical models to optimize detection rates
12. Maternal serum hCG at 15 weeks is a predictor for preeclampsia
13. Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin
14. A retrospective evaluation of second-trimester serum for fetal trisomy 18: Experience of two laboratories
15. Ultrasonographic diagnosis of trisomy 18: Is it practical in the early second trimester?
16. Prenatal screening for trisomy 18 with free β human gonadotropin as a marker
17. Second trimester levels of pregnancy associated plasma protein-A in cases of trisomy 18
18. Choroid plexus cysts: Is biochemical testing a valuable adjunct to targeted ultrasonography?
19. Screening for trisomy 18 by fetal nuchal translucency and maternal serum free β-hCG and PAPP-A at 10-14 weeks of gestation
20. An economic evaluation of prenatal strategies for detection of trisomy 18
21. Maternal serum screening for Down's syndrome in early pregnancy